3/31/2023  5:29:48 PM Chg. -0.05 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
9.10EUR -0.54% 703,562
Turnover: 2.58 mill.
-Bid Size: - -Ask Size: - 7.52 bill.EUR 1.76% 10.12

Business description

Grifols S.A., headquartered in Barcelona, Spain, is a global healthcare company with a track-record of more than 75 years improving people’s health and well-being through the development of plasma protein therapies, hospital pharmacy products and diagnostic technology for clinical use. They have three primary divisions: Bioscience, Diagnostic and Hospital. The company is present in more than 100 countries worldwide and its headquarters are located in Barcelona, Spain. Grifols is a leader in plasma collection with a network of 160 plasma donation centers in the U.S., and is a leading producer of plasma-derived medicines. As a recognized leader in transfusion medicine, Grifols offers a comprehensive range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks, and transfusion centers.

Management board & Supervisory board

Management board
Raimon Grífols Roura, Víctor Grífols Deu
Supervisory board
Víctor Grifols Roura, Belén Villalonga Morenés, Carina Szpilka Lázaro, Enrique Felip Font, Iñigo Sánchez- Asiaín Mardones, James Costos, Marla E.Salmon, Raimon Grífols Roura, Ramon Riera Roca, Steven F. Mayer, Thomas Glanzmann, Tomás Dagá Gelabert, Víctor Grífols Deu

Company data

Name: Grifols S.A.
Address: Avinguda de la Generalitat, 152, Parque empresarial Can Sant Joan,ES-08174 Sant Cugat del Vallès, Barcelona
Phone: +34-93-5712200
Fax: +34-93-5710267
E-mail: grifols@grifols.com
Internet: www.grifols.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Medical Supplies
End of financial year: 12/31
Free Float: 100.00%
IPO date: -

Investor relations

Name: -
IR phone: +34-93-5710221
IR Fax: +34-93-5712201
IR e-mail: inversores@grifols.com

Main Shareholders